Proteomic analyses have already been performed and associated to clinical phenotype in SSc (29–32), as shown by the report that the higher expression of CXCL4 from peripheral blood and skin plasmacytoid dendritic cells in association with the incidence and progression of ILD and PAH in SSc (33). Here, PF4 is linked to systemic sclerosis.